Drug company Bayer has joined a scheme that aims to promote blister packs for medicines using fibre instead of plastics.
It has become a member of the Blister Pack Collective, which was set up by PA Consulting and Swedish R&D company PulPac.
Dry moulded fibre technology is used to produce a blister pack that allows for the same amount of tablets, but uses 80% less CO2 in production than plastic. It could also save on the 100,000 tonnes of PVC plastic used for tablet packaging each year.
PA Consulting Pulpac partnership lead Tony Perrotta said: “We are excited to welcome Bayer to the Blister Pack Collective. PA and PulPac formed the Blister Pack Collective to accelerate the progress to reduce single-use plastics, especially problem plastics like PVC, in over-the-counter, prescription drugs, nutraceuticals, and confectionary items.
“We are delighted to join forces with leading brand partners like Bayer to accelerate development and create a global impact.”
Bayer Consumer Health director global packaging innovation Jesse DelGigante added: “We have a bold commitment to transform 100% of our packaging to be recyclable or renewable by 2030 and have committed to invest €100 million investment in changing how our products are made and consumed. Achieving this will require working with the best partners and we are proud to be a part of the Blister Pack Collective as we work to make a real impact for sustainability.”
